New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

A new handheld medical device could potentially replace a stethoscope as a tool for detecting valvular heart disease, say ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

An innovative, minimally invasive procedure is reducing the risk faced by patients with heart valve disease and improving ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

The main cause of Gene Hackman’s death was heart disease, but he was also in the advanced stages of Alzheimer’s disease and ...

Complications weren’t more common when leads were extracted. Yet there’s also the option of “jailing” leads instead.

Congenital heart disease is an issue with the heart’s structure at birth, according to the Cleveland Clinic, and can prevent ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

A grandmother has been given a “second chance at life” after undergoing a world-first heart valve operation. Julia ...

As it aims to broaden the reach of its replacement heart valves among younger patients, Edwards Lifesciences has put forward new clinical data showing its bioprosthetics can maintain their ...

When I talk I get quite emotional,” she tails off. Julia first had two of her heart valves replaced in 2007. Her heart was being monitored at the time after a murmur had been detected.